Benzinga | Apr 29, 2021 06:58AM EDT

RBC Capital Downgrades Adverum Biotechnologies to Sector Perform, Announces $6 Price Target

RBC Capital downgrades Adverum Biotechnologies (NASDAQ:ADVM) from Outperform to Sector Perform and announces $6 price target.